Approved Formulary
Add Formweb to your mobile device
Approved Formulary
Black Box Warning: Lidocaine viscous should not to be used to treat teething pain
Search results for:
LIDOCAINE
LIDOCAINE
- PALS Drug Administration Guidelines PALS Lidocaine Infusion
- Black Box Warning: Lidocaine viscous should not to be used to treat teething pain
| Drug Name | Form | Strength | Non-Formulary | Notes |
|---|---|---|---|---|
| XYLOCAINE-MPF | INJECTION | 0.5% | ||
| LIDOCAINE HYDROCHLORIDE, INJECTABLE | INJECTION | 1% | ||
| XYLOCAINE-MPF | INJECTION | 1% | ||
| LIDOCAINE HYDROCHLORIDE, INJECTABLE | INJECTION | 1.5% | ||
| XYLOCAINE-MPF | INJECTION | 1.5% | ||
| LIDOCAINE HYDROCHLORIDE, INJECTABLE | INJECTION | 2% | ||
| XYLOCAINE HCL | INJECTION | 2% | ||
| XYLOCAINE-MPF | INJECTION | 2% | ||
| XYLOCAINE-MPF | INJECTION | 4% | ||
| LIDOCAINE HYDROCHLORIDE, INJECTABLE | INJECTION | 20% | ||
| LIDOCAINE FOR INFUSION | STANDARD CONCENTRATION (GMC) | 8 mg/ml |
View Other Therapeutic Options: Class Ib Antiarrhythmics:
24040408
Last updated: Aug. 30, 2018
- Drug Administration Guidelines Click here for administration guidelines